Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryn Nelson

Showing results (131-140 of 186) with videos related to

Pageof 19
Sort By:
Cancer Cytopathology|December 2, 2025
A new push to revive transperineal prostate biopsies: Amid growing concerns over transrectal biopsy infections and antibiotic resistance, the case for a transperineal alternative is not yet a sure thingBryn Nelson, William Faquin
Cancer Cytopathology|December 12, 2022
Cancer-linked genetic testing: Growing panels and challenges in the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United StatesBryn Nelson, William Faquin
Cancer Cytopathology|June 19, 2025
Untangling the mystery of rising breast cancer rates: In this first of a two-part series on new investigations into rising breast and colorectal cancer rates, researchers are grappling with spiking rates of specific breast cancers, particularly among younger womenBryn Nelson, William Faquin
Cancer Cytopathology|October 3, 2025
A daunting quest to map the reach and risk of nanoplastics: In this second of a two-part series on early studies of microplastics and nanoplastics, researchers have found tiny particles throughout the human body but warn that quantifying and reducing the risk may be difficultBryn Nelson, William Faquin
Cancer Cytopathology|February 3, 2024
Heightened but variable COVID-19 risks for patients with cancer: Multiple studies have underscored certain cancer-associated dangers while reaffirming the protective effects of vaccination and other prevention strategiesBryn Nelson, William Faquin
Cancer Cytopathology|August 1, 2024
Exposing the naked truth about how mole-rats evade cancer: In this first of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, researchers are exploring how adaptations to their extreme environment may have given naked mole-rats potent cancer-fighting toolsBryn Nelson, William Faquin
Cancer Cytopathology|November 2, 2024
Cancer-aiding elements begin illuminating the genome's "dark matter": Within what was once deemed useless junk, virus-like retrotransposons, long noncoding RNAs, and other exotic molecules have emerged as beacons for cancer researchersBryn Nelson, William Faquin
Cancer Cytopathology|April 7, 2026
Bridging the global diversity gap in cancer genomics: Ambitious new collaborations are aiming to create valuable cancer genomics databases that better reflect real-world diversityBryn Nelson, William Faquin
Cancer Cytopathology|May 5, 2026
Funding cuts and mixed messages threaten the rise of mRNA vaccine technology: Researchers express deep concern over cuts to the vaccine science that could boost cancer immunotherapyBryn Nelson, William Faquin
Cancer Cytopathology|July 1, 2026
New progress in addressing cancer pain: Recent studies have offered revealing insights into predisposing, precipitating, and perpetuating factors as well as underlying mechanisms and potential interventionsBryn Nelson, William Faquin
Pageof 19

Showing results (131-140 of 186) with videos related to

Sort By:
Pageof 19
Cancer Cytopathology|December 2, 2025
A new push to revive transperineal prostate biopsies: Amid growing concerns over transrectal biopsy infections and antibiotic resistance, the case for a transperineal alternative is not yet a sure thingBryn Nelson, William Faquin
Cancer Cytopathology|December 12, 2022
Cancer-linked genetic testing: Growing panels and challenges in the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United States: In this first of a two-part series, genetic testing is promising more targeted approaches to prevention and intervention for hereditary cancers, but new recommendations are running up against communication challenges and differences even within the United StatesBryn Nelson, William Faquin
Cancer Cytopathology|June 19, 2025
Untangling the mystery of rising breast cancer rates: In this first of a two-part series on new investigations into rising breast and colorectal cancer rates, researchers are grappling with spiking rates of specific breast cancers, particularly among younger womenBryn Nelson, William Faquin
Cancer Cytopathology|October 3, 2025
A daunting quest to map the reach and risk of nanoplastics: In this second of a two-part series on early studies of microplastics and nanoplastics, researchers have found tiny particles throughout the human body but warn that quantifying and reducing the risk may be difficultBryn Nelson, William Faquin
Cancer Cytopathology|February 3, 2024
Heightened but variable COVID-19 risks for patients with cancer: Multiple studies have underscored certain cancer-associated dangers while reaffirming the protective effects of vaccination and other prevention strategiesBryn Nelson, William Faquin
Cancer Cytopathology|August 1, 2024
Exposing the naked truth about how mole-rats evade cancer: In this first of a two-part series on what we can learn from unusually cancer-resistant or -susceptible animals, researchers are exploring how adaptations to their extreme environment may have given naked mole-rats potent cancer-fighting toolsBryn Nelson, William Faquin
Cancer Cytopathology|November 2, 2024
Cancer-aiding elements begin illuminating the genome's "dark matter": Within what was once deemed useless junk, virus-like retrotransposons, long noncoding RNAs, and other exotic molecules have emerged as beacons for cancer researchersBryn Nelson, William Faquin
Cancer Cytopathology|April 7, 2026
Bridging the global diversity gap in cancer genomics: Ambitious new collaborations are aiming to create valuable cancer genomics databases that better reflect real-world diversityBryn Nelson, William Faquin
Cancer Cytopathology|May 5, 2026
Funding cuts and mixed messages threaten the rise of mRNA vaccine technology: Researchers express deep concern over cuts to the vaccine science that could boost cancer immunotherapyBryn Nelson, William Faquin
Cancer Cytopathology|July 1, 2026
New progress in addressing cancer pain: Recent studies have offered revealing insights into predisposing, precipitating, and perpetuating factors as well as underlying mechanisms and potential interventionsBryn Nelson, William Faquin
Pageof 19